Element Biosciences Establishes Scientific Advisory Board

Leading Scientists from Stanford, University of Chicago, and Wellcome Sanger Institute Strengthen Element’s R&D Expertise and Innovation Engine SAN DIEGO, CA – Element Biosciences, Inc., developer of the Element AVITI System, an innovative DNA sequencing platform that is disrupting the genomics industry, today announced the formation of its Scientific Advisory Board with four leading experts on genomics, oncology, chemistry, [...]

Thermo Fisher Scientific Completes Acquisition of CorEvitas

Advances World-Class Clinical Research Capabilities with Leading Regulatory-Grade Registries Platform Expected to Be Accretive to Adjusted Earnings Per Share 1 WALTHAM, Mass. -- Thermo Fisher Scientific Inc. (NYSE: TMO) (“Thermo Fisher”), the world leader in serving science, today announced that it has completed the acquisition of CorEvitas, LLC (“CorEvitas”), a leading provider of regulatory-grade, real-world evidence [...]

ArcticZymes Technologies launches AZtaq™ DNA Polymerase

  Tromsø, Norway – ArcticZymes Technologies ASA (OSE: AZT) launches AZtaq™ DNA Polymerase. ArcticZymes Technologies (AZT) today announces the launch of its new product, AZtaq™ DNA Polymerase. AZtaq™ is a high-quality thermostable DNA polymerase suitable for use in polymerase chain reaction (PCR) applications. Launching the AZtaq™ is a natural expansion of the Company’s molecular tools portfolio. [...]

Release of the ICPMS-2040 Series and ICPMS-2050 Series ICP Mass Spectrometers

Contributing to research and development of pharmaceuticals, the environment, and foods via analysis of hazardous elements and essential minerals with a reduced environmental load Image of products: ICPMS-2050 inductively coupled plasma mass spectrometer and AS-20 autosampler Shimadzu Corporation announces the release of the ICPMS-2040 Series and ICPMS-2050 Series inductively coupled plasma mass spectrometers (ICP-MS) for [...]

ERS Genomics & Santa Cruz Biotechnology Enter Into CRISPR/Cas9 Licensing Agreement

License allows Santa Cruz Biotechnology to develop and commercialize products using CRISPR/Cas9. Dublin, Ireland and Dallas, Texas:  ERS Genomics Limited (‘ERS’) is pleased to announce a new license agreement with Santa Cruz Biotechnology Inc (‘SCBT,’). This is a non-exclusive licensing agreement granting SCBT access to the ERS CRISPR/Cas9 patent portfolio. ERS founder, Dr. Emmanuelle Charpentier, [...]

Oxford Nanopore releases update to MinKNOW™ software to accelerate basecalling analysis, further accelerating high-throughput projects, at scale

The accelerated nanopore basecaller “Dorado” is now integrated into the device software MinKNOW, to enable basecalling and broad methylation analysis in real time  Oxford Nanopore today announced the integration of an accelerated basecaller into the device software MinKNOW. These improvements enable the sequencing of approximately 2,500* human genomes a year on a PromethION 24 (at [...]

BioFlyte Raises $5.4M in Series B Financing to Protect Critical Infrastructure from Airborne Biothreats

New financing will help scale manufacturing of BioFlyte’s novel biothreat surveillance solution to expand reach within aviation and mail screening applications ALBUQUERQUE, N.M. – BioFlyte, a biothreat detection firm with a revolutionary new class of fieldable biological threat collection, detection, and identification solutions, today announced that it raised $5.4M in new financing led by Scout Ventures and Cottonwood Technology Fund with [...]

South Carolina-Based Imcs, Tymora Analytical Partner To Streamline Exosome Research — Imcs

Integrated Micro-Chromatography Systems, Inc. ("IMCS"), a leader in automating laboratory workflows, and Tymora Analytical, an authority in exosome purification and proteomics services, have announced a significant enhancement to their ongoing collaboration to advance exosome research. The partnership began in 2017 with phosphoproteomics, where Tymora's unique chemistries were packaged in IMCStips, a pipette-based purification tool to [...]

Healthcare specialist SHS Capital acquires majority stake in ESSERT

With SHS Capital's investment in ESSERT GmbH, both companies are pooling their expertise in the pharmaceutical and life science sectors. ESSERT GmbH was founded in Ubstadt-Weiher in 2012 and is a provider of scalable and flexible robot automation solutions. Right from the start, ESSERT strategically focused on production areas that are confronted with increasing product [...]

Dr. Steven Barnard Appointed Chief Technology Officer

SAN DIEGO -- Illumina, Inc. (NASDAQ: ILMN), a global leader in DNA sequencing and array-based technologies, today announced Dr. Steven Barnard, Illumina's Vice President and Head of Global Advanced Science, will serve as its next Chief Technology Officer (CTO), effective immediately. Dr. Alex Aravanis, who held the position of CTO, will be departing Illumina to [...]

Access IBO on Knowledge Center